In the Media

September 27, 2024

The Lower Rio Grande Valley has one of the highest obesity rates in the United States, which, according to Dr. Christopher Romero, PI at Headlands Research Brownsville, can be, in part, attributed to a genetic component for Indigenous Americans. Learn more in this article from My RGV.

September 24, 2024

Headlands Research is launching its newest site on the U.S.-Mexico border in El Paso, Texas. Learn more about the site opening in this article from Fierce Biotech.

September 2, 2024

Sepsis is a medical emergency that kills nearly 270,000 Americans yearly. However, only 55% of Americans have heard of it. Learn more about the disease from Dr. Christopher Romero, Principal Investigator (PI) at Headlands Research Brownsville, in this article from Valley Central.

July 16, 2024

Earlier this year, Headlands Research CEO, Kyle Burtnett joined other experts as a panelist for a discussion on Clinical Trial Site Management Organizations (SMOs) during a session at the inaugural Pharma and MedTech Services Investment Summit. Learn more in this article from McDermott Will & Emery.

June 12, 2024

Drinking water, daily exercise, and a healthy diet are three lifestyle changes men can make to improve their health. Read more from Dr. Christopher Romero, Medical Director for Headlands Research and Principal InvestigatorHeadlandsResearch Brownsville, in this article from MyRGV.

April 3, 2024

Headlands Research has opened its fifth and final research site under its multi-year partnership with Pfizer to increase the diversity of participants in clinical trials. Learn more in this article from Fierce Biotech.

February 29, 2024

Headlands Research has acquired Pharmasite Research. Learn more in this article from Fierce Biotech.

February 26, 2024

Belinda Russell, Dir. of Recruitment Strategy, at Headlands Research, discusses how to achieve inclusive clinical trial enrollment in this article from International Clinical Trials.

July 27, 2023

Headlands Research acquires AMCR Institute. Learn more in this article from Applied Clinical Trials.

June 28, 2023

Headlands Research taps Kyle Burtnett to replace Cathy Collins as CEO. Learn more in this article from Fierce Biotech.

May 10, 2023

Headlands Research acquires Clinvest Research. Learn more in this article from Applied Clinical Trials.

April 19, 2023

Headlands Research has acquired an established clinical research site, now known as Headlands Research Eastern Massachusetts. Learn more in this article from Fierce Biotech.

April 19, 2023

Headlands acquires clinical research site in Massachusetts. The company plans to expand its network of clinical trial sites throughout the year. Learn more in this article from Clinical Trials Arena.

April 19, 2023

Headlands Research acquires eastern Massachusetts–based research site. Learn more in this article from Applied Clinical Trials.

April 18, 2023

Headlands Research acquires established eastern Massachusetts–based research site specializing in neurodegenerative diseases. Learn more in this article from StreetInsider.com.

April 17, 2023

Artemis: Driving better clinical trial results through patient-focused methodology. Learn more in this article from Life Sciences Review.

March 24, 2023

California firm expands network with launch of metro Detroit-based clinical trial site. Learn more in this article from DBusiness.

May 20, 2022

Headlands, Pfizer collaborate to boost clinical trial diversity. Under the collaboration, the first trial site will be opened at a new facility of Headlands in Brownsville, Texas, US. Learn more in this article from Clinical Trials Arena.

May 20, 2022

ASCO, ACCC become latest to call for clinical trial diversity with 6 strategies for improving inclusion in cancer studies. Learn more in this article from Fierce Biotech.

May 19, 2022

Pfizer teams up with Headlands Research to launch trial sites in more diverse areas. Learn more in this article from Fierce Biotech.

May 19, 2022

Pfizer, Headlands Research partner to bring trials to highly diverse areas. Learn more in this article from BioSpace.

April 13, 2021

Backed by KKR & Co., Headlands Research has conducted clinical trials for multiple COVID-19 vaccine candidates. Learn more from the Wall Street Journal.

September 2, 2020

Man who lost 7 relatives to COVID-19 becomes first American to trial Oxford vaccine at Headlands Research Jem Research Institute in Lake Worth, Florida. Learn more in this article from CBS News.